CH678599A5 - - Google Patents

Download PDF

Info

Publication number
CH678599A5
CH678599A5 CH3749/87A CH374987A CH678599A5 CH 678599 A5 CH678599 A5 CH 678599A5 CH 3749/87 A CH3749/87 A CH 3749/87A CH 374987 A CH374987 A CH 374987A CH 678599 A5 CH678599 A5 CH 678599A5
Authority
CH
Switzerland
Prior art keywords
pro
injection
urokinase
infusion
administered
Prior art date
Application number
CH3749/87A
Other languages
German (de)
English (en)
Inventor
Dieter Dr Welzel
Helmut Dr Wolf
Original Assignee
Vascular Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB868623823A external-priority patent/GB8623823D0/en
Priority claimed from GB868628741A external-priority patent/GB8628741D0/en
Priority claimed from GB878707551A external-priority patent/GB8707551D0/en
Priority claimed from GB878715678A external-priority patent/GB8715678D0/en
Application filed by Vascular Lab filed Critical Vascular Lab
Publication of CH678599A5 publication Critical patent/CH678599A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/49Urokinase; Tissue plasminogen activator

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CH3749/87A 1986-10-03 1987-09-28 CH678599A5 (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB868623823A GB8623823D0 (en) 1986-10-03 1986-10-03 Therapeutic lysis of fibrin blood clots
GB868628741A GB8628741D0 (en) 1986-12-02 1986-12-02 Therapeutic lysis of fibrin blood clots
GB878707551A GB8707551D0 (en) 1987-03-30 1987-03-30 Therapeutic lysis of fibrin blood clots
GB878715678A GB8715678D0 (en) 1987-07-03 1987-07-03 Therapeutic lysis of fibrin blood clots

Publications (1)

Publication Number Publication Date
CH678599A5 true CH678599A5 (pt) 1991-10-15

Family

ID=27449820

Family Applications (1)

Application Number Title Priority Date Filing Date
CH3749/87A CH678599A5 (pt) 1986-10-03 1987-09-28

Country Status (19)

Country Link
KR (1) KR960002738B1 (pt)
AU (1) AU7932587A (pt)
BE (1) BE1002058A4 (pt)
CA (1) CA1323300C (pt)
CH (1) CH678599A5 (pt)
DE (1) DE3731776A1 (pt)
DK (1) DK519287A (pt)
FI (1) FI874320A (pt)
FR (1) FR2605225B1 (pt)
GR (1) GR871528B (pt)
HU (1) HUT47032A (pt)
IL (1) IL84061A0 (pt)
IT (1) IT1230114B (pt)
LU (1) LU87007A1 (pt)
MY (1) MY101943A (pt)
NL (1) NL8702234A (pt)
NO (1) NO874143L (pt)
PT (1) PT85848B (pt)
SE (1) SE466531B (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8503097A (nl) * 1985-11-11 1987-06-01 Leuven Res & Dev Vzw Geneesmiddel met thrombolytische werking.

Also Published As

Publication number Publication date
BE1002058A4 (fr) 1990-06-12
SE466531B (sv) 1992-03-02
DE3731776A1 (de) 1988-05-05
MY101943A (en) 1992-02-15
FR2605225B1 (fr) 1994-02-04
NO874143L (no) 1988-04-05
DK519287A (da) 1988-04-04
AU7932587A (en) 1988-04-14
HUT47032A (en) 1989-01-30
FI874320A0 (fi) 1987-10-01
KR880004821A (ko) 1988-06-27
PT85848B (en) 1990-01-12
NO874143D0 (no) 1987-10-01
FR2605225A1 (fr) 1988-04-22
KR960002738B1 (ko) 1996-02-26
IT1230114B (it) 1991-10-07
DK519287D0 (da) 1987-10-02
LU87007A1 (fr) 1988-05-03
CA1323300C (en) 1993-10-19
IL84061A0 (en) 1988-03-31
GR871528B (en) 1988-02-23
SE8703788L (sv) 1988-04-04
FI874320A (fi) 1988-04-04
NL8702234A (nl) 1988-05-02
SE8703788D0 (sv) 1987-10-01
PT85848A (en) 1987-11-01
IT8748444A0 (it) 1987-10-02

Similar Documents

Publication Publication Date Title
DE69130289T2 (de) Therapeutische verwendung von actin-bindenden verbindungen
DE69503120T3 (de) Zusammensetzungen aus einer thrombolytisch wirkende substanz und antikoagulantien, und ihre verwendungen
DE69828462T2 (de) Verwendung von APC, in Kombination mit Blutplättchenaggregationshemmer, zur Behandlung thrombothischer Störungen
DE69429429T2 (de) MODIFIZIERTER FAKTOR VII zur Hemmung der vaskulären Restenosis und Thrombozytenablagerung
DE3689943T2 (de) Degradierte Spezies eines Gewebeplasminogenaktivators, pharmazeutische Zubereitung und Verfahren zur Herstellung derselben.
DE69325393T2 (de) Pharmazeutische zusammensetzungen und verfahren unter verwendung von isobutyramid zur behandlung von betaglobinerkrankungen
DE4411143C2 (de) Thrombosemittel
DE3876348T2 (de) Thrombolytisches agens.
EP1622639B1 (de) Intravenöse injektion nicht-neurotoxischer plasminogen-aktivatoren zur behandlung von schlaganfall
EP0625908B1 (de) Antidot für hirudin und synthetische thrombininhibitoren
EP1308166B1 (de) Nicht-neurotoxische Plasminogen Aktivierende Faktoren zur Behandlung von Schlaganfällen
US5055295A (en) Lysis of fibrin blood clots with urokinase and pro-urokinase
DE60301862T2 (de) Kombinationsbehandlung bei akutem myokardinfarkt
DE69905489T2 (de) Protein c zur behandlung von sichelzellanämie und thalassämie
CH678599A5 (pt)
DE69317343T2 (de) Verwendung eines direkten Inhibitors von Thrombin zur Herstellung eines Arzneimittels mit thrombolytischer Aktivität
DE69532123T2 (de) Thrombolytische zusammensetzungen
DE69000290T2 (de) Thrombotische zusammensetzungen.
EP0458929B1 (de) t-PA-Solubilisierung
DE69724818T2 (de) Medizinische Verwendung des scuPA/suPAR Komplexes
DE68908716T2 (de) Heparin enthaltende formulierungen.
DE60004185T2 (de) Supar stimulierende aktivität auf die tcupa vermittelte fibrinolyse und verschiedene verwendungen davon
DE3686684T2 (de) Mittel zur absorptionsverbesserung von proteinen.
DE3586795T2 (de) Absorptionsverbesserer fuer proteine.
EP0733371B1 (de) Mittel zur subkutanen Verabreichung von Protein C

Legal Events

Date Code Title Description
PL Patent ceased